Basilea Pharmaceutica AG (SWX:BSLN)
43.25
+1.15 (2.73%)
Apr 24, 2025, 4:41 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 510.68 million as of April 24, 2025. Its market cap has decreased by -0.36% in one year.
Market Cap
510.68M
Enterprise Value
501.64M
Revenue
208.54M
Ranking
n/a
PE Ratio
7.23
Stock Price
43.25
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has decreased from 533.29M to 510.68M, a decrease of -4.24%. That is a compound annual growth rate of -0.21%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 204.82B |
Novartis AG | 171.98B |
Lonza Group AG | 38.09B |
Alcon | 37.28B |
Galderma Group AG | 18.65B |
Straumann Holding AG | 15.45B |
Sonova Holding AG | 14.13B |
Sandoz Group AG | 14.01B |